NCT05660070

Brief Summary

This open trial will test a new technology-supported blended intervention, mobile Social Interaction Therapy by Exposure (mSITE), that targets social engagement in consumers with serious mental illness.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable schizophrenia

Timeline
Completed

Started Jul 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2022

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

December 5, 2022

Completed
16 days until next milestone

First Posted

Study publicly available on registry

December 21, 2022

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 6, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 6, 2024

Completed
Last Updated

December 6, 2024

Status Verified

December 1, 2024

Enrollment Period

2.2 years

First QC Date

December 5, 2022

Last Update Submit

December 4, 2024

Conditions

Outcome Measures

Primary Outcomes (5)

  • Ecological Momentary Assessment

    EMA is a method of remote data collection that involves repeatedly sampling a participant's current behaviors, thoughts, mood, and experiences in real time, in their natural environments. The primary outcome in this study will be the number of social interactions.

    Assess change from baseline in number of social interactions at Weeks 0, 8, 12, 18, and 24

  • Clinical Assessment Interview for Negative Symptoms

    Measure changes in motivational negative symptoms on the CAINS. The CAINS is a 13-item interview-based assessment of negative symptoms, and each item is rated from 0 (no impairment) to 4 (severe deficit) measuring the two negative symptom factors recommended in consensus reports: Expression and Motivation and Pleasure (MAP) across social, vocational and recreational domains. Total scores for each factor are computed. The range for the MAP is 0 - 36, and the range for the Expression factor is 0 - 16. Higher scores indicate more severe negative symptoms for both factors.

    Assess change from baseline in expression and motivation and pleasure at Weeks 0, 8, 12, 18, and 24

  • Birchwood Social Functioning Scale

    Measure changes in functioning on the Birchwood Social Functioning Scale (SFS). The SFS is a self-report assessment of functioning with 7 subscales, and each item is rated from 0 to 3 with the exception of the Occupation/Employment subscale if a participant is in regular employment (scores range from 7-10 based upon type of work). The subscales and score ranges are: Social Engagement Withdrawal (0-15), Interpersonal Communication/Relationships (0-30), Prosocial Activities (0-66), Recreation (0-48), Independence-Performance (0-39), Independence-Competence (0-39), and Occupation/Employment (0-10). Higher scores indicate better functioning for all subscales.

    Assess change from baseline in social functioning at Weeks 0, 8, 12, 18, and 24

  • Positive And Negative Syndrome Scale

    The PANSS is a 30-item interview that provides balanced representation of positive and negative symptoms and gauges their relationship to one another and to global psychopathology. Items are rated 1 (Absent) to 7 (Extreme) and summed across items for a total range of scores of 30-210. Higher scores indicate the presence of more severe symptoms.

    Assess change from baseline in positive and negative symptoms at Weeks 0, 8, 12, 18, and 24

  • Passive sensing mobile application

    The passive sensing mobile application will measure the number of conversations. The conversations or specific content will not be recorded.

    Assess change from baseline in number of conversations at Weeks 0, 8, 12, 18, and 24

Study Arms (1)

mobile Social Interaction Therapy by Exposure (mSITE)

EXPERIMENTAL

mSITE is a blended intervention that integrates brief in-person psychotherapy with context-triggered mobile smartphone intervention and remote telephone coaching.

Behavioral: mobile Social Interaction Therapy by Exposure (mSITE)

Interventions

mSITE is a blended intervention that integrates brief in-person psychotherapy with context-triggered mobile smartphone intervention and remote telephone coaching.

mobile Social Interaction Therapy by Exposure (mSITE)

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Voluntary informed consent to participate and capacity to consent;
  • Age 18 to 65;
  • DSM-5 diagnosis of schizophrenia, schizoaffective, bipolar I disorder or major depression with history of psychosis based on a SCID-5 interview and available medical record review;
  • Minimum level of social avoidance defined by a score of ≥ 2 on the Scale for the Assessment of Negative Symptoms (SANS) asociality item;
  • ≥ 6th grade reading level on the Wide Range Achievement Test-4 Reading subtest (to read therapy workbook).

You may not qualify if:

  • Prior CBT in the past 2 years;
  • Greater than moderate disorganization on the PANSS (P2- Disorganization item \>5);
  • DSM-5 alcohol or substance dependence in past 3 months based on the SCID;
  • Level of care required interferes with outpatient therapy (e.g., hospitalized; severe medical illness)
  • Unable to adequately see or manually manipulate a phone;
  • Resident of an integrated housing facility that also provides treatment services.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UC San Diego

La Jolla, California, 92093, United States

Location

MeSH Terms

Conditions

SchizophreniaPsychotic DisordersAffective Disorders, Psychotic

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Study Officials

  • Eric Granholm, PhD

    University of California, San Diego; San Diego Veterans Healthcare System

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Single Group Assignment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

December 5, 2022

First Posted

December 21, 2022

Study Start

July 1, 2022

Primary Completion

September 6, 2024

Study Completion

September 6, 2024

Last Updated

December 6, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will share

Per terms of the award, participant-level data will be uploaded to the NIMH Data Archive (NDA).

Time Frame
Data will be uploaded according to NDA standard data submission periods. These periods are currently twice each year.
Access Criteria
Data access is outlined in the current NDA Policy.
More information

Locations